Follow up to the Maseru Declaration. ZIMBABWE COUNTRY REPORT
Reporting Period: January 2013 - December 2013
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...r vaccine against coronavirus disease 2019 (COVID-19). The vaccine expresses the SARS-CoV-2 spike protein gene, which instructs the host cells to produce the protein of the S-antigen unique to SARS-CoV-2, allowing the body to generate an immune response and to retain that information in memory immune cells. Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) irrespective of interval between the doses was 63.1%, based on a median follow-up of 80 days, but tended to be higher when this interval was longer. The data reviewed at this time support the conclusion that the known and potential benefits of ChAdOx1-S/nCoV-19 [recombinant] vaccine outweigh the known and potential risks.
more
Resources for the Prevention and Treatment of Substance Use Disorders (SUD)
Migration & health position paper series
Cross-cutting health themes
Tuberculosis, Migration and human mobility
The five hepatitis viruses have different epidemiological profiles, and their impact, duration, and transmission route also vary. The most common transmission routes contributing to the spread of hepatitis are exposure to infected blood via blood transfusion or unsafe injection practices, consumptio...n of contaminated food and drinking water, and transmission from mother to child during pregnancy and delivery. Also, unsafe injection practices, including the use of unsterile needles and syringes, serve as a major pathway for the spread of hepatitis B and C, and reducing transmission of both diseases requires addressing these practices.
more
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Техническая записка;
Целью настоящей Технической записки является оказание содействия кандидатам наполучение грантов Глобального фонда при рассмотрении ...возможностей включения программ, направленных на устранение барьеров, обусловленных нарушением прав человека и гендерным неравенством, которые препятствуют получению услуг по профилактике, диагностике и лечению туберкулеза (ТБ), в запросы на финансирование, а также оказание помощивсем заинтересованным сторонам в том, чтобы программы по борьбе с ТБ обеспечивали продвижение и защиту прав человека и гендерного равенства.
more